 |
인쇄하기
취소
|
PuriMed announces Phase II clinical trial of lotus seed in depression patients
PuriMed, a local biopharmaceutical company, has recently announced the commencement of the Phase II clinical trial in patients with depression using a natural product PM011 (trade name: Lotuzol).
This control, double-blind Phase II clinical trial, which has been accepted by the Korea Food and Drug Administration (KFDA), will be undertaken by enrolling 136 patients from four local university ...
This control, double-blind Phase II clinical trial, which has been accepted by the Korea Food and Drug Administration (KFDA), will be undertaken by enrolling 136 patients from four local university ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.